CAP modulation of INS and glucose activity in a sex-dependent manner has implications not only for understanding the ability of CAP to improve female, but not male, performance in power sports but also for the use of CAP as a adjuvant for some types of cancer therapies. The gene discussed is INS; the disease is cancer.